Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779842 · ClinicalTrials.gov registry record · NA
Sun Protection Factor - Assay
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02779842: Completed NA study, sponsored by Bayer.
NCT02779842 is a NA study that has completed, run by Bayer. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02779842, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To evaluate the Sun Protection Factor efficacy on human skin.
Interventions
- DRUG Coppertone (BAY 987517)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-07-29 |
| Est. Completion | 2015-08-11 |
| Phase | NA |
What the finished NCT02779842 record still lists
NCT02779842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Coppertone (BAY 987517) is the first listed.
NCT02779842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02779842 about?
NCT02779842 is a clinical study titled "Sun Protection Factor - Assay". To evaluate the Sun Protection Factor efficacy on human skin.
What is the current status of trial NCT02779842?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2015-07-29. Estimated completion is 2015-08-11.
What interventions are being tested in trial NCT02779842?
The interventions under investigation include: Coppertone (BAY 987517) (DRUG).
Who is sponsoring clinical trial NCT02779842?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02779842's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI